Vexler Vladimir 4
4 · Coherus BioSciences, Inc. · Filed Jan 6, 2023
Insider Transaction Report
Form 4
Vexler Vladimir
Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
[F1][F2]2023-01-04$9.87/sh−5,437$53,663→ 98,527 total - Award
Stock Option (Right to Buy)
[F3]2023-01-04+80,000→ 80,000 totalExercise: $9.87Exp: 2033-01-04→ Common Stock (80,000 underlying)
Footnotes (3)
- [F1]Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.
- [F2]Includes 1 share acquired on November 15, 2022, pursuant to Coherus BioSciences, Inc. Employee Stock Purchase Plan.
- [F3]The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 4, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
Signature
/s/ McDavid Stilwell, as Attorney-in-Fact for Vladimir Vexler|2023-01-06